Soligenix, Inc. ( SNGX) - Key Metrics
SNGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
SNGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
SNGX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -19.66% | ? |
| 2025Q4 | -20.28% | ? |
| 2025Q3 | -58.40% | ? |
| 2025Q2 | -63.91% | ? |
| 2025Q1 | -28.17% | ? |
SNGX
Price: $0.40
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.14 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16498
Ebitda: -951647Market Capitalization: 4.6 million